Alfakim Amikacin Inj IP 500mg 2ml represents a trusted pharmaceutical solution for combating severe bacterial infections in clinical environments. This sterile aminoglycoside antib...
Alfakim Amikacin Inj IP 500mg 2ml represents a trusted pharmaceutical solution for combating severe bacterial infections in clinical environments. This sterile aminoglycoside antibiotic injection is specifically engineered to address complex medical cases requiring broad-spectrum activity against gram-negative organisms. Manufactured under stringent quality control protocols, each 2ml vial contains precisely 500mg of amikacin, ensuring consistent dosing and therapeutic reliability. The injection comes in secure bottle packaging with a substantial 24-month shelf life, making it an optimal choice for hospital inventories and medical supply networks. Healthcare providers rely on this medication for its proven efficacy in critical situations where patient outcomes depend on rapid, effective antibacterial intervention.
This antibiotic injection serves extensive applications across multiple healthcare sectors including hospital critical care units, surgical departments, emergency medicine, and infectious disease specialties. Medical practitioners utilize it for treating serious conditions such as septicemia, complicated urinary tract infections, respiratory tract infections, and post-operative complications. The medication proves particularly valuable in clinical settings where antibiotic resistance has developed against other treatments, serving as a crucial second-line defense in antimicrobial therapy protocols. Its established reliability makes it a fundamental component in hospital formularies, clinical pharmacies, and emergency medical services where prompt response to severe infections is essential for patient survival and recovery.
For healthcare institutions and medical distributors, Alfakim Amikacin Injection delivers substantial value through its consistent quality, reliable performance, and extended shelf life. The product's standardized formulation ensures predictable therapeutic outcomes, minimizing treatment uncertainties in critical care scenarios. Medical procurement teams appreciate the straightforward storage requirements and durable packaging that maintains product integrity throughout distribution channels. The prescription-only status confirms its professional-grade nature, while the proven clinical track record builds confidence among healthcare providers. This combination of clinical effectiveness and operational dependability makes it a strategic investment for hospitals, clinics, and medical distributors seeking trustworthy antibiotic solutions.
Key Features:
- Precisely formulated 500mg/2ml dosage in sterile injection form
- Broad-spectrum activity against gram-negative and select gram-positive bacteria
- Secure bottle packaging with tamper-evident protection
- Extended 24-month shelf life for efficient inventory management
- Prescription-grade quality meeting international pharmaceutical standards
Benefits:
- Effective treatment for severe bacterial infections resistant to other antibiotics
- Reliable performance in critical care and hospital settings
- Consistent dosing accuracy for predictable therapeutic outcomes
- Extended shelf life reduces waste and improves inventory management
- Trusted solution backed by quality manufacturing and clinical validation